Home | Sitemap | Contact Us     Search Ranbaxy for  
  Quick Links
 
 
   
   
 
    
 
     
 
   
 
 


Home
> Business Development & Partnerships

Business Development & Partnerships

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, headquartered in India, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. It is ranked amongst the top ten generic companies worldwide. The Company has manufacturing operations in 11 countries with a ground presence in 49 countries and its products are available in over 125 countries. The Company is driven by its ambition to achieve US $5 Bn Sales by 2012 and be amongst the top five generic players worldwide. To translate these objectives into reality and to optimize value creation, the Company has adopted a multi-pronged strategy. Acquisition of generic brands overseas, strong emphasis on brand marketing in the US and Europe, entering high potential new markets with value added product offerings, are the major thrust areas. Successful business development transactions form a key component of it's business strategy.

In each of our partnerships, we strive to build enduring, mutually beneficial relationships that can produce positive results for both parties.

We are interested in sales and marketing partnerships and product acquisition opportunities in all the markets where we operate. We are exploring opportunities through Licensing and Alliances to draw maximum value from such arrangements. We continue to evaluate opportunities to add to our product basket, enhance our therapeutic presence and expand our distribution reach.

We are also interested in building winning drug discovery and development collaborations in the following therapeutic areas:

 
Anti-infectives
  Inflammation & Respiratory
  Metabolic Diseases
  Oncology

In addition, we have active R&D programs in oral controlled release drug delivery systems and are looking for suitable partnerships. We are also actively evaluating options for acquiring new technology platforms to develop differentiated high margin products.

For business development, licensing, and partnership enquiries please contact:


Dr. Shyam Bishen, Ph.D., MBA

Vice President, Corporate Development

Ranbaxy Pharmaceuticals Inc.
600 College Road East
Princeton, NJ 08540, USA
Phone: 001 (609) 720-5377
E-mail: shyam.bishen@ranbaxy.com